NOISE DETECTION AND RESPONSE FOR USE WHEN MONITORING FOR ARRHYTHMIAS

• US 20100312131A1
• Filed: 06/09/2009
• Published: 12/09/2010
• Est. Priority Date: 06/09/2009
• Status: Abandoned Application

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Naware, Mihir, Xi, Cecilia Qin
• Application Number:
  US12/481,434
• Publication Number:
  US 20100312131A1
• Time in Patent Office: Days
• US Class Current: 600/518
• CPC Class Codes: A61B 5/287 Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
• CPC Class Codes: A61B 5/318 Heart-related electrical modalities, e.g. electrocardiography [ECG]
• CPC Class Codes: A61B 5/361 Detecting fibrillation
• CPC Class Codes: A61B 5/412 Detecting or monitoring sepsis
• CPC Class Codes: A61B 5/7203 for noise prevention, reduction or removal
• CPC Class Codes: A61B 5/721 using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured

Abstract

Methods and systems of noise detection and response for use when monitoring for arrhythmias are described herein. At least two electrodes are used to obtain a signal indicative of cardiac electrical activity. The signal is bandpass filtered to obtain a filtered signal. Ventricular depolarizations are monitored for based on comparisons of the filtered signal to a first threshold. Arrhythmias are monitored for based on ventricular depolarization detections that occur as a result of monitoring for ventricular depolarizations. During one or more noise detection windows, noise is monitored for and a likelihood that monitoring for arrhythmias is adversely affected by noise is determined based on results thereof. Whether and/or how the monitoring for arrhythmias is performed is modified when it is determined that monitoring for arrhythmias is likely adversely affected by noise.

Claims

1. A method of noise detection and response for use when monitoring for arrhythmias, comprising:

(a) using at least two electrodes to obtain a signal indicative of cardiac electrical activity;

(b) bandpass filtering the signal to obtain a filtered signal;

(c) monitoring for ventricular depolarizations based on comparisons of the filtered signal to a first threshold;

(d) monitoring for arrhythmias based on ventricular depolarization detections that occur as a result of the monitoring at step (c);

(e) monitoring for noise during one or more noise detection windows;

(f) determining, based on results of the monitoring for noise, when it is likely that the monitoring for arrhythmias is adversely affected by noise; and

(g) modifying whether and/or how the monitoring for arrhythmias is performed, when it is determined that the monitoring for arrhythmias is likely adversely affected by noise.

2. The method of claim 1, wherein steps (d) is performed before step (e), step (e) is performed before step (d), or step (d) and step (e) are performed simultaneously.

3. The method of claim 1, wherein the signal is one of an electrocardiogram (ECG) signal and an intracardiac electrogram (IEGM) signal.

4. The method of claim 3, wherein step (a) comprises:

using at least two electrodes implanted subcutaneously to obtain a subcutaneous ECG signal;

using at least two non-implanted surface electrodes to obtain a surface ECG signal;

or

using at least two electrodes implanted within or on the heart to obtain an IEGM signal.

5. The method of claim 1, wherein step (b) comprises bandpass filtering the signal to achieve an effective frequency range of about 8.5 Hz to about 30 Hz.

6. The method of claim 1, wherein step (c) comprises determining a ventricular depolarization detection when the filtered signal crosses the first threshold.

7. The method of claim 1, wherein step (d) comprises monitoring for at least ventricular tachyarrhythmia (VT) and atrial fibrillation (AF).

8. The method of claim 1, wherein step (e) comprises monitoring for noise based on comparisons of portions of the filtered signal, corresponding to the noise detection windows, to a second threshold having a lower magnitude than the first threshold.

9. The method of claim 8, wherein step (e) includes determining that noise is detected within a noise detection window based on how many times the portion of the filtered signal, corresponding to the noise detection window, crosses the second threshold.

10. The method of claim 8, wherein the second threshold is a specified percentage of the first threshold, with the specified percentage having a lower limit of about 25% and an upper limit of about 85%.

11. The method of claim 8, wherein:

step (e) comprises monitoring for noise during a plurality of back-to-back noise detection windows; and

each said noise detection window comprises a length of time having a lower limit of about 90 ms and an upper limit of about 250 ms.

12. The method of claim 11, wherein each said noise detection window is about 125 ms.

13. The method of claim 11, wherein step (e) includes determining that noise is detected within a noise detection window if the portion of the filtered signal, corresponding to the noise detection window, crosses the second threshold at least N times, wherein N is an integer ≧

1.

14. The method of claim 13, wherein N is an integer ≧

4.

15. The method of claim 1, wherein step (f) comprises determining that it is likely that the monitoring for arrhythmias is adversely affected by noise, if noise detections occurred for a specified number of the immediately preceding ventricular depolarization windows.

16. The method of claim 15, wherein step (f) comprises determining that it is likely that the monitoring for arrhythmias is adversely affected by noise, if noise detections occurred for X out of the last Y immediately preceding ventricular depolarization windows, where Y is an integer ≧

2, and X is an integer ≦

Y.

17. The method of claim 1, wherein when it is determined that the monitoring for arrhythmias is likely adversely affected by noise, step (g) comprises one of the following:

inhibiting monitoring for arrhythmias;

ignoring arrhythmia detections; and

storing information about arrhythmia detections along with an indication that the arrhythmia detections occurred when it was determined that the monitoring for arrhythmias was likely adversely affected by noise.

18. The method of claim 1, wherein step (g) comprises entering a noise mode, when it is determined that the monitoring for arrhythmias is likely adversely affected by noise, wherein during the noise mode:

arrhythmias are continued to be monitored for at step (d); and

information about arrhythmia detections are stored along with at least one marker indicating that the arrhythmia detections occurred when the monitoring for arrhythmias was likely adversely affected by noise.

19. The method of claim 18, wherein the at least one marker comprises:

a noise entry marker; and

a noise exit marker.

20. The method of claim 1, wherein step (g) comprises entering an inhibit mode, when it is determined that the monitoring for arrhythmias is likely adversely affected by noise, wherein during the inhibit mode:

arrhythmias are not monitored for at step (d);

or

arrhythmias are monitored for at step (d), but information about arrhythmia detections are not stored.

21. An implantable device, comprising:

one or more sensing circuits configured to obtain, using at least two electrodes, a signal indicative of cardiac electrical activity;

one or more filters configured to filter the signal to obtain a bandpass filtered signal;

one or more monitors, processors and/or controllers configured to

detect ventricular depolarizations based on comparisons of the bandpass filtered signal to a first threshold;

monitor for arrhythmias based on ventricular depolarization detections;

monitor for noise during one or more noise detection windows;

determine when it is likely that the arrhythmia monitoring is adversely affected by noise; and

modify whether and/or how the arrhythmias are to be monitored for, when it is determined that the arrhythmia monitoring is likely adversely affected by noise.

22. The implantable device of claim 21, wherein the controller is configured to monitor for arrhythmias and monitor for noise at different times and/or at the same time.

23. The implantable device of claim 21, wherein:

the implantable device comprises a cardiac monitoring device that does not have stimulation capabilities;

the at least two electrodes are configured to be implanted subcutaneously; and

the signal obtained by the one or more sensing circuits comprises a subcutaneous electrocardiogram.

24. The implantable device of claim 21, wherein:

the implantable device comprises a cardiac stimulation device configured to pace and/or shock a patient'"'"'s heart;

the at least two electrodes are configured to be implanted within and/or on a patient'"'"'s heart; and

the signal obtained by the one or more sensing circuits comprises an intracardiac electrogram.

25. The implantable device of claim 21, wherein when the one or more monitors, processors and/or controllers determine that arrhythmia monitoring is likely adversely affected by noise, the one or more monitors, processors and/or controllers are configured to:

inhibit monitoring for arrhythmias;

ignore arrhythmia detections;

or store information about arrhythmia detections along with an indication that the arrhythmia detections occurred when it was determined that the arrhythmia monitoring was likely adversely affected by noise.

26. A non-implantable device, comprising:

one or more sensing circuits configured to obtain, using at least two surface electrodes, a signal indicative of cardiac electrical activity;

one or more filters configured to filter the signal to obtain a bandpass filtered signal;

one or more monitors, processors and/or controllers configured to

detect ventricular depolarizations based on comparisons of the bandpass filtered signal to a first threshold;

monitor for arrhythmias based on ventricular depolarization detections;

monitor for noise during one or more noise detection windows;

determine when it is likely that the arrhythmia monitoring is adversely affected by noise; and

modify whether and/or how the arrhythmias are to be monitored for, when it is determined that the arrhythmia monitoring is likely adversely affected by noise.

27. The non-implantable device of claim 26, wherein when the one or more monitors, processors and/or controllers determine that arrhythmia monitoring is likely adversely affected by noise, the one or more monitors, processors and/or controllers are configured to:

inhibit monitoring for arrhythmias;

ignore arrhythmia detections;

store information about arrhythmia detections along with an indication that the arrhythmia detections occurred when it was determined that the monitoring for arrhythmias was likely adversely affected by noise;

or

display information about arrhythmia detections along with an indication that the arrhythmia detections occurred when it was determined that the monitoring for arrhythmias was likely adversely affected by noise.